"Focusing on strategies for drug repurposing and development of novel drug combinations for cancer therapeutics" 

The conference will focus on screening approaches (academic and industrial) dependent upon advanced models linked to imaging, including variations on 3D and co-culture microscopy, high-end multiplexing, deep image data mining, and technology development. 


Invited Speakers Include:
 
David Andrews, Ph.D., University of Toronto, Canada
Geoffrey Bartholomeusz, Ph.D., M.D. Anderson ...

One of the great challenges to developing new drugs for cancer treatment is to select therapeutic targets whose activity is critical to the survival of particular types of cancer cells. Much more challenging is the identification of those molecules, or more often, those networks of molecules, whose dysregulation plays a critical ...

Significant advances in drugging difficult targets have been developed in academic and industrial research centers and have begun to be utilized in high-throughput screens towards validating efficacy and identifying functional phenotypes. The goal of our upcoming Symposium is to provide illustrations of novel classes of therapeutic agents that have been ...

Significant advances in cancer therapeutics have created new opportunities for the development of combinatorial therapies that optimize the therapeutic benefit to patients without an attendant increase in toxicity.  Presentations will include illustrations of successful pre-clinical and clinical strategies for the development of novel therapeutic combinations as well as a discussion ...